ADIAL (ADIL) 10% Owner Coastlands Capital Buys Shares

What Happened
Coastlands Capital LP, reported as a 10% owner of ADIAL PHARMACEUTICALS, INC. (ADIL), bought a total of 3,233 shares in two purchase transactions. On 2026-07-14 Coastlands purchased 2,000 shares at $2.65 each ($5,300 total). On 2026-07-16 it purchased 1,233 shares at $2.75 each ($3,391 total). These were purchases (transaction code P), which are generally considered more informative than routine sales since they represent added ownership.

Key Details

• Transaction dates and prices:
  • 2026-07-14: 2,000 shares @ $2.65 = $5,300
  • 2026-07-16: 1,233 shares @ $2.75 = $3,391
• Total acquired: 3,233 shares for $8,691.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing timeliness: Form 4 was filed 2026-07-16 for trades on 7/14 and 7/16 — appears timely (not reported as late).
• Footnote: The filing notes Coastlands Capital LP and related entities (including Coastlands Capital GP LLC and Coastlands GP) and that Matthew Perry is the control person; the filers disclaim group membership and beneficial ownership except to the extent of pecuniary interest (see F1).

Context
This is institutional buying by a reported 10% owner rather than an individual executive. Purchases recorded as "P" indicate outright acquisitions (open market or private). The filing provides factual trade details but does not reveal the buyer’s motivation.